MEI Pharma announced positive preclinical data for its orally administered drug, voruciclib. Voruciclib blocks CDK9, a cyclin-dependent kinase (CDK) inhibitor and hinders growth …
MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced updated results from a Phase II …
MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced new pre-clinical data showing mitochondria-specific …
Cowen analyst Boris Peaker reiterated an Outperform rating on MEI Pharma (NASDAQ:MEIP), as the company reported clinical activity from a Phase II study of …
Brean Capital analyst Jonathan Aschoff maintained a Buy rating on MEI Pharma (NASDAQ:MEIP) with a $16 price target, which represents a potential upside of …
In a research report sent to investors today, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on MEI Pharma (NASDAQ:MEIP) with a …
In a research report issued today, Roth Capital analyst Joseph Pantginis maintained a Buy rating on MEI Pharma (NASDAQ:MEIP) with a price target …
In a research report released yesterday, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on MEI Pharma (NASDAQ:MEIP) with a price target …
In a research note released yesterday, Brean Capital analyst Jonathan Aschoff reaffirmed a Buy rating on MEI Pharma (NASDAQ:MEIP) with a $16 price …
In a research report issued yesterday, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on MEI Pharma (NASDAQ:MEIP) with a price target …
